When discussing the dangers of smoking, most people think of lung cancer, heart disease, and respiratory illness. However, smoking has wide-ranging effects that extend to every part of the body—including the prostate. The prostate is a small gland in the male reproductive system, yet it plays an essential role in urinary and sexual function. At 1Prostate Center, located in Manhattan and Queens and led by Dr. David Shusterman, patients are increasingly asking about lifestyle factors that impact prostate health. Smoking, as it turns out, is linked to poorer prostate cancer outcomes as well as erectile dysfunction and bladder cancer.
Increased Risk of Prostate Cancer
Smoking has been associated with several types of cancer, and the prostate is no exception. Although smoking has not been linked to a higher chance of being diagnosed with prostate cancer, more recent and comprehensive research shows that men who smoke are more likely to die from the disease. The carcinogens found in tobacco smoke don’t just remain in the lungs—they circulate through the bloodstream, exposing every organ to their harmful effects. These toxins may contribute to the development of cancerous cells within the prostate or worsen preexisting conditions.
Notably, smoking is associated with more advanced stages of prostate cancer at diagnosis and poorer prognoses. Men who smoke are more likely to have high-grade tumors, meaning the cancer is more aggressive and fast-growing. Additionally, smokers face a higher risk of cancer recurrence after treatment, including surgery or radiation therapy. This suggests that smoking doesn’t just influence whether prostate cancer develops—it also impacts how it behaves and how effectively it can be treated.
Reduced Effectiveness of Prostate Cancer Treatment
For men undergoing treatment for prostate cancer, smoking presents additional challenges. It can reduce the body’s ability to heal after surgery, increase the risk of complications, and interfere with the success of radiation or hormone therapy. Some studies show that smokers are more likely to experience side effects from radiation treatment and have lower survival rates following a prostate cancer diagnosis.
Smoking affects oxygen delivery throughout the body, including to tissues that are recovering after prostatectomy or radiation. Poor circulation can delay wound healing and increase the likelihood of infections or long-term scarring. In men receiving hormone therapy, smoking may also blunt the therapy’s effectiveness, making it harder to control the growth of cancer cells. This compounding effect makes smoking one of the most significant modifiable factors influencing prostate cancer outcomes.
Inflammation and Prostatitis Risk
Chronic inflammation is believed to play a role in the development and progression of many prostate disorders. Smoking contributes to systemic inflammation, which can impact the prostate and increase the risk of conditions such as prostatitis. Prostatitis, or inflammation of the prostate gland, can be acute or chronic and may result in pelvic pain, painful urination, and sexual dysfunction.
The toxic chemicals in tobacco can irritate tissues throughout the urinary and reproductive systems, triggering immune responses that lead to localized swelling and discomfort. In chronic cases, this inflammation may persist even in the absence of infection, making symptoms difficult to manage. Whether smoking makes prostatitis more likely to recur or harder to treat has not been well studied.
Effects on Hormones and Testosterone Levels
The relationship between smoking and hormone balance is complex, and studies of tobacco use and male reproductive hormones have produced conflicting results. Some studies have suggested that smoking may affect hormones like dihydrotestosterone (DHT), which is associated with prostate growth and enlargement. At the same time, large population studies have actually found somewhat higher total testosterone levels in smokers, so hormonal changes are unlikely to explain smoking’s harms.
The possible consequences of these hormonal changes for prostate health remain unclear. It has been suggested that an imbalance in DHT could promote benign prostatic hyperplasia (BPH), a non-cancerous enlargement of the prostate that causes urinary issues, but pooled studies have not found a clear link between smoking and BPH. Smoking’s well-established damage to blood vessels, nerves, and the bladder better explains why smokers report a range of urologic concerns.
Impact on Urinary Function
One of the most noticeable effects of prostate problems is difficulty with urination. Men may experience a weak stream, urgency, frequency, or a sensation of incomplete emptying. These symptoms are commonly linked to BPH or prostatitis, and some men find that smoking makes them worse, although research on smoking and urinary symptoms is limited and inconsistent.
Smoking is also a major cause of bladder cancer, which can cause urinary symptoms that overlap with prostate problems, such as frequency, urgency, or blood in the urine. Any new urinary symptoms in a smoker, especially blood in the urine, should be evaluated promptly.
Erectile Dysfunction and Sexual Health
Prostate health is closely tied to sexual function, and smoking is a well-documented risk factor for erectile dysfunction (ED). Poor circulation caused by smoking limits blood flow to the penis, making it difficult to achieve or maintain an erection. For men already dealing with prostate conditions, adding smoking to the mix may further diminish quality of life by compounding both urinary and sexual difficulties.
Beyond circulation, smoking can impair nerve function and lead to vascular damage that affects the pelvic region. Over time, this damage reduces sensitivity and responsiveness, interfering with sexual performance. Prostate conditions like prostatitis or post-treatment recovery from cancer can already strain sexual health, so maintaining optimal blood flow and nerve function is crucial. Smoking directly undermines these systems, making recovery more difficult and symptoms more persistent.
Potential Benefits of Quitting Smoking
While the consequences of smoking are serious, the good news is that quitting can produce substantial benefits—even for men who have smoked for many years. Smoking cessation is associated with reduced inflammation, improved circulation, and enhanced immune function. These improvements can support prostate healing, increase the effectiveness of cancer treatments, and improve long-term health outcomes.
Within a few weeks of quitting, blood pressure begins to normalize, and oxygen levels improve. Over time, the risk of heart disease, stroke, and many cancers decreases. For the prostate specifically, men who stop smoking may lower their risk of dying from prostate cancer and of recurrence after treatment; in one large study, men who had quit for at least ten years had prostate cancer death rates similar to men who never smoked. These gains are even more significant when combined with other healthy lifestyle changes such as a balanced diet, regular physical activity, and appropriate medical screenings.
Takeaway for Men in Manhattan and Queens
Smoking is a powerful factor in many aspects of health, but its impact on the prostate is often underestimated. From worse prostate cancer outcomes to erectile dysfunction and bladder cancer, tobacco use undermines male health at multiple levels. For men in Manhattan and Queens seeking to protect their prostate health, quitting smoking is one of the most impactful decisions they can make. Recognizing the connection between smoking and prostate disorders is a crucial first step toward prevention, early intervention, and improved outcomes over the long term.
Sources
- A systematic review and meta-analysis of tobacco use and prostate cancer mortality and incidence in prospective cohort studies. Eur Urol, 2014.
- Smoking and prostate cancer survival and recurrence. JAMA, 2011.
- Association of Smoking Status With Recurrence, Metastasis, and Mortality Among Patients With Localized Prostate Cancer Undergoing Prostatectomy or Radiotherapy: A Systematic Review and Meta-analysis. JAMA Oncol, 2018.
- Smoking and risk of erectile dysfunction: systematic review of observational studies with meta-analysis. PLoS One, 2013.
- Harms of Cigarette Smoking and Health Benefits of Quitting. National Cancer Institute.
Share this blog!
Facebook Twitter LinkedInRecent Post
Managing Chronic Prostatitis: Natural Remedies That Help
Read More »
The Role of Curcumin in Prostate Health
Read More »